Literature DB >> 12975611

The contribution of in vivo manipulation of gene expression to the understanding of the function of glypicans.

Jorge Filmus1.   

Abstract

The name glypican identifies a family of heparan sulfate proteoglycans that are linked to the cell surface by a glycosylphosphatidylinositol anchor. Members of this family have been identified in Drosophila, zebrafish, and mammals. The interest in the study of glypicans has increased in the last few years as a result of the discovery that the glypican-3 gene (GPC-3) is mutated in an overgrowth and dysmorphic syndrome. Despite the increased interest, our knowledge about the function of glypicans is still limited, since the molecular basis for the role of glypican-3 in the regulation of body size remains unknown. The in vivo manipulation of glypican expression in lower organisms, however, has demonstrated that these proteoglycans can modulate cellular responses to Wnts and bone morphogenetic factors. Future studies should investigate whether the phenotype of GPC-3-deficient individuals is also due to altered modulation of cellular responses to these factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12975611     DOI: 10.1023/A:1025312819804

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  46 in total

1.  Regulation of dally, an integral membrane proteoglycan, and its function during adult sensory organ formation of Drosophila.

Authors:  M Fujise; S Izumi; S B Selleck; H Nakato
Journal:  Dev Biol       Date:  2001-07-15       Impact factor: 3.582

2.  Neuronal expression of glypican, a cell-surface glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan, in the adult rat nervous system.

Authors:  E D Litwack; C S Stipp; A Kumbasar; A D Lander
Journal:  J Neurosci       Date:  1994-06       Impact factor: 6.167

3.  Glypicans: a growing trend.

Authors:  R Weksberg; J A Squire; D M Templeton
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

4.  Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signalling.

Authors:  X Lin; N Perrimon
Journal:  Nature       Date:  1999-07-15       Impact factor: 49.962

5.  A new X-linked mental retardation-overgrowth syndrome.

Authors:  M Golabi; L Rosen
Journal:  Am J Med Genet       Date:  1984-01

6.  Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.

Authors:  G Pilia; R M Hughes-Benzie; A MacKenzie; P Baybayan; E Y Chen; R Huber; G Neri; A Cao; A Forabosco; D Schlessinger
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

Review 7.  Clinical and molecular aspects of the Simpson-Golabi-Behmel syndrome.

Authors:  G Neri; F Gurrieri; G Zanni; A Lin
Journal:  Am J Med Genet       Date:  1998-10-02

Review 8.  Report of another family with Simpson-Golabi-Behmel syndrome and a review of the literature.

Authors:  C L Garganta; J N Bodurtha
Journal:  Am J Med Genet       Date:  1992-09-15

9.  A new X-linked dysplasia gigantism syndrome: identical with the Simpson dysplasia syndrome?

Authors:  A Behmel; E Plöchl; W Rosenkranz
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.

Authors:  D F Cano-Gauci; H H Song; H Yang; C McKerlie; B Choo; W Shi; R Pullano; T D Piscione; S Grisaru; S Soon; L Sedlackova; A K Tanswell; T W Mak; H Yeger; G A Lockwood; N D Rosenblum; J Filmus
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

View more
  16 in total

1.  Meta-analysis and systematic review of prognostic significance of Glypican-3 in patients with hepatitis B-related hepatocellular carcinoma.

Authors:  Bita Moudi; Zahra Heidari; Hamidreza Mahmoudzadeh-Sagheb
Journal:  Virusdisease       Date:  2019-03-28

2.  Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients.

Authors:  Su Ning; Chen Bin; Huang Na; Shen Peng; Ding Yi; Ye Xiang-hua; Zeng Fang-yin; Zheng Da-yong; Luo Rong-cheng
Journal:  Mol Biol Rep       Date:  2011-06-08       Impact factor: 2.316

3.  Hepatocellular tumors: immunohistochemical analyses for classification and prognostication.

Authors:  Regina Cheuk-Lam Lo; Irene Oi-Lin Ng
Journal:  Chin J Cancer Res       Date:  2011-12       Impact factor: 5.087

4.  Hypervascular hepatocellular carcinomas showing hyperintensity on hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging: a possible subtype with mature hepatocyte nature.

Authors:  Norihide Yoneda; Osamu Matsui; Azusa Kitao; Ryuichi Kita; Kazuto Kozaka; Wataru Koda; Satoshi Kobayashi; Toshifumi Gabata; Hiroko Ikeda; Yasuni Nakanuma
Journal:  Jpn J Radiol       Date:  2013-06-16       Impact factor: 2.374

5.  Mutations in the heparan-sulfate proteoglycan glypican 6 (GPC6) impair endochondral ossification and cause recessive omodysplasia.

Authors:  Ana Belinda Campos-Xavier; Danielle Martinet; John Bateman; Dan Belluoccio; Lynn Rowley; Tiong Yang Tan; Alica Baxová; Karl-Henrik Gustavson; Zvi U Borochowitz; A Micheil Innes; Sheila Unger; Jacques S Beckmann; Lauréane Mittaz; Diana Ballhausen; Andrea Superti-Furga; Ravi Savarirayan; Luisa Bonafé
Journal:  Am J Hum Genet       Date:  2009-05-28       Impact factor: 11.025

Review 6.  Biomarkers for the early diagnosis of hepatocellular carcinoma.

Authors:  Nobuhiro Tsuchiya; Yu Sawada; Itaru Endo; Keigo Saito; Yasushi Uemura; Tetsuya Nakatsura
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

7.  Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin-fixed tumor vaccine, with special reference to glypican-3.

Authors:  Issei Kawashima; Yuri Kawashima; Yasuo Matsuoka; Kiyotaka Fujise; Hideki Sakai; Mari Takahashi; Toshiaki Yoshikawa; Tetsuya Nakatsura; Takeshi Ishihara; Tadao Ohno
Journal:  Clin Case Rep       Date:  2015-04-17

Review 8.  Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies.

Authors:  Danijel Galun; Tatjana Srdic-Rajic; Aleksandar Bogdanovic; Zlatibor Loncar; Marinko Zuvela
Journal:  J Hepatocell Carcinoma       Date:  2017-07-11

Review 9.  Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment.

Authors:  Mengtao Xing; Xinzhi Wang; Robert A Kiken; Ling He; Jian-Ying Zhang
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

10.  Peptide vaccines for hepatocellular carcinoma.

Authors:  Daisuke Nobuoka; Toshiaki Yoshikawa; Yu Sawada; Toshiyoshi Fujiwara; Tetsuya Nakatsura
Journal:  Hum Vaccin Immunother       Date:  2013-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.